Screening Colonoscopy Improves CRC-Related Mortality in Veterans

Share this content:
Colonoscopy was associated with a significant reduction in CRC mortality among veterans.
Colonoscopy was associated with a significant reduction in CRC mortality among veterans.

Colonoscopy is associated with significant reductions in colorectal cancer (CRC) mortality among veterans and with greater benefit for left-sided cancer than right-sided cancer, according to a study published in the Annals of Internal Medicine.

Charles J. Kahi, MD, MSc, from the Richard L. Roudebush VA Medical Center and Indiana University School of Medicine in Indianapolis, and colleagues conducted a case-control study to determine whether colonoscopy is associated with decreased CRC mortality in veterans and whether its effect differs by anatomical location of CRC. The sampling frame included veterans with inpatient and/or outpatient visits at any VA facility from 1997 to 2010. Patients were veterans who received a diagnosis of CRC when they were aged 50 years or older and died of CRC when they were aged 52 years or older. Patients were identified from January 1, 2002, to December 31, 2002, and died of CRC between January 1, 2002, and December 31, 2010.

Exposure was defined as receipt of colonoscopy between January 1, 1997, and 6 months before CRC diagnosis in case patients. Subgroup analysis was performed for patients who had undergone screening colonoscopy.

A total of 4,964 case patients and 19,856 control patients were identified. The mean age was 70.7 years (SD, 10.0), and 99.3% were male. A total of 668 case patients and 5,250 control patients were exposed to colonoscopy; the indication was diagnostic in 68.7% and 60.9%, screening in 15.3% and 21.3%, and surveillance in 16.0% and 17.8%, respectively. Median time between colonoscopy and CRC diagnosis was 43.5 months (range, 6 to 141 months) among case patients. The proportions of patients who underwent colonoscopy for a screening indication were 8.0% from 1997 to 2001, 32.2% from 2002 to 2006, and 32.6% in 2007 or later.

Case patients were significantly less likely to have undergone any colonoscopy (OR, 0.39). Colonoscopy was associated with reduced mortality for left-sided cancer (OR, 0.28) and right-sided cancer (OR, 0.54). The results were similar for patients who had undergone screening colonoscopy (overall OR, 0.30). Sensitivity analyses that varied the interval between CRC diagnosis and colonoscopy exposure did not affect the primary findings.

“In this study using national VA–Medicare data, colonoscopy was associated with a 61% reduction in CRC mortality among veterans,” the authors stated. “This reduction was observed for both left- and right-sided CRC, although the association was weaker for right-sided cancer (46% vs 72% mortality reduction). These trends were also observed in the screening colonoscopy subgroup.”

Click here for more information on National Colorectal Cancer Awareness Month. 

Reference

Kahi CJ, Pohl H, Myers LJ, Mobarek D, Robertson DJ, Imperiale TF. Colonoscopy and colorectal cancer mortality in the Veterans Affairs Health Care System: a case–control study. Ann Intern Med. 13 March 2018. doi: 10.7326/M17-0723. [Epub ahead of print].

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs